A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study

Starting soon

Conditions studied: Medullary Thyroid Cancer

In brief

Clinical studies, with a distinct emphasis on medullary thyroid cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications surpass conventional therapies, providing substantial evidence to endorse their broader adoption. The primary objective is to meticulously examine trial completion rates and voluntary withdrawals within this specific patient group. By actively participating in this observational study plays a critical role in pushing medical knowledge forward and advancing care for individuals suffering from the medullary thyroid cancer.

Key facts

Study ID

NCT06079723

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-11-01

Expected to finish

2026-11-01

Last updated by the study team

2023-10-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of medullary thyroid cancer
• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• No serious medical or psychiatric illness likely to interfere with participation in this clinical study.

You may not qualify if…

• Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• Any serious and/or unstable pre-existing medical disorders
• Patients who are currently receiving any other investigational drug.

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.